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ABSTRACT
Yeast prions are a group of non-Mendelian genetic elements transmitted as altered and self-propagating
conformations. Extensive studies in the last decade have provided valuable information on the mech-
anisms responsible for yeast prion propagation. How yeast prions are formed de novo and what cellular
factors are required for determining prion ‘‘strains’’ or variants—a single polypeptide capable of existing
in multiple conformations to result in distinct heritable phenotypes—continue to defy our understand-
ing. We report here that Sse1, the yeast ortholog of the mammalian heat-shock protein 110 (Hsp110) and
a nucleotide exchange factor for Hsp70 proteins, plays an important role in regulating ½PSI1 de novo
formation and variant determination. Overproduction of the Sse1 chaperone dramatically enhanced
½PSI1 formation whereas deletion of SSE1 severely inhibited it. Only an unstable weak ½PSI1 variant was
formed in SSE1 disrupted cells whereas ½PSI1 variants ranging from very strong to very weak were formed
in isogenic wild-type cells under identical conditions. Thus, Sse1 is essential for the generation of multiple
½PSI1 variants. Mutational analysis further demonstrated that the physical association of Sse1 with Hsp70
but not the ATP hydrolysis activity of Sse1 is required for the formation of multiple ½PSI1 variants. Our
findings establish a novel role for Sse1 in ½PSI1 de novo formation and variant determination, implying
that the mammalian Hsp110 may likewise be involved in the etiology of protein-folding diseases.
IN the budding yeast Saccharomyces cerevisiae, the non-Mendelian genetic element ½PSI1 is referred to as a
prion because it is epigenetically transmitted as altered
and amyloid-like protein conformations (Wickner 1994;
King and Diaz-Avalos 2004; Tanaka et al. 2004). This
protein-based transmission is similar to that of a group
of mammalian neurodegenerative diseases known as
transmissible spongiform encephalopathies, or prion
diseases (Prusiner 1998). The protein determinant of
½PSI1 is Sup35, a subunit of the translation termination
factor that directs ribosomes to faithfully terminate at
stop codons (Stansfield et al. 1995). When Sup35 en-
ters a prion conformation, it is sequestered from its na-
tural binding partner, Sup45, and occasionally results
in translational readthrough. Therefore, ½PSI1 cells
that contain a nonsense mutation in an ADE gene, such
as ade1-14, are capable of growing in medium lacking
adenine whereas the isogenic nonprion (½psi) cells are
not (Cox 1965; Firoozan et al. 1991). Due to the accu-
mulation of a pigment by-product, ½psi cells appear red
on rich growth media, e.g., on YPD, but ½PSI1 cells ap-
pear white. Thus, ½PSI1 and ½psi cells can be easily distin-
guished in the laboratory due to the dramatic differences
in their growth requirements and colony appearances
(Cox 1965). This convenient assay, in combination with
the powerful genetics available in budding yeast, has made
½PSI1 a valuable model for prion research (Liebman
and Derkatch 1999; Serio and Lindquist 1999; Soto
and Castilla 2004).
The formation and maintenance of ½PSI1 requires
interaction of Sup35 with endogenous cellular factors.
Molecular chaperones, a group of proteins that exercise
protective functions inside the cell by refolding or dis-
aggregating denatured proteins, are important compo-
nents of the cellular machineries required for prion
formation and propagation (Pirkkala et al. 2001). For
example, Hsp104, a member of the Hsp100 family, Ssa
and Ssb, members of the Hsp70 family, and Ydj1 and
Sis1, members of the Hsp40 family, have been impli-
cated in playing important roles in ½PSI1 propagation
(Chernoff et al. 1995; Jung et al. 2000; Kushnirov et al.
2000; Jung and Masison 2001; Sondheimer et al. 2001;
Allen et al. 2005). The Hsp90 co-chaperones Sti1 and
Cpr7 are also known to influence ½PSI1 stability in the
context of the mutant ssa1-21 strain harboring an SSA1
point mutation that destabilizes ½PSI1 ( Jones et al. 2004).
Although ½PSI1 propagation has been extensively in-
vestigated and important insights have been gained
regarding the mechanisms of its transmission, the ½PSI1
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initiation process is less well understood. We have recently
reported that two truncation mutants of the heat-shock
transcription factor (HSF) strongly influence ½PSI1 initia-
tion. An HSF mutant lacking the carboxyl-terminal acti-
vation domain, DCTA-HSF, dramatically increases ½PSI1
de novo formation, whereas a mutant lacking the amino-
terminal activation domain, DNTA-HSF, severely inhibits
this process (Park et al. 2006). Interestingly, DCTA-HSF
preferentially allows the formation of weak and mosaic
½PSI1 variants (Park et al. 2006). This finding demon-
strates that the carboxyl-terminal activation domain of
HSF (CTA-HSF) regulates the expression of important
factors required for ½PSI1 formation and variant deter-
mination. To date, five proteins have been conclusively
identified as CTA-HSF targets: Hsp90, Sse1, Sti1, Ydj1, and
Cpr6 (Liu and Thiele 1999). When Hsp90 was overpro-
duced, no significant effects were observed on preexisting
½PSI1 (Newnam et al. 1999). Neither overexpression nor
deletion of CPR6 had detectable effects on ½PSI1 propa-
gation ( Jones et al.2004). Overexpression ofYDJ1 cured a
weak ½PSI1 and a hybrid ½PSI1, ½PSI1(PS), but had no
notable influence on a strong ½PSI1 variant (Kushnirov
et al. 2000). Overall, STI1 overexpression weakened or
destabilized whereas sti1D strengthened ½PSI1 ( Jones
et al. 2004). Recently, Sse1, an Hsp90 co-chaperone and a
nucleotide exchange factor (NEF) for the cytosolic Ssa
and Ssb proteins, was identified as a novel regulator of
½PSI1 propagation (Kryndushkin and Wickner 2007).
Despite their importance in ½PSI1 propagation, whether
these CTA-HSF targets play any roles in regulating ½PSI1
de novo formation and variant determination has not been
investigated. We report here that manipulating the ex-
pression levels of individual CTA-HSF target genes can
result in dramatic influences on ½PSI1 de novo formation.
We show that Sse1 not only is important for ½PSI1 pro-
pagation but also is required for ½PSI1 de novo formation
and variant determination. In addition, results from mu-
tational analysis also demonstrate that Sse1 correlates the
NEF activity of Sse1 with ½PSI1 manipulation. Our find-
ings have therefore established Sse1 as an important regu-
lator in ½PSI1 biology and raise the possibility that Hsp70
cofactors play critical roles in amyloidoses in higher
organisms.
MATERIALS AND METHODS
Plasmids: Plasmids used in this study are listed in Table 1. To
generate the plasmid pRS305-HSF1, pRS314HSF1 was digested
with XbaI and XhoI. The resulting fragment of 3901 bp was
ligated to pRS305-C, which had been predigested withXbaI and
XhoI. To create pRS305-DCTAHSF1, polymerase chain reaction
(PCR) was carried out using the 59 primer (59-AAAGGCCT
TAATGAATAGTACACAGGGCAAGGTC-39), the 39 primer
(59-AGGCACCCCAGGCTTTAC-39), and pRS305HSF1 as the
DNA template. PCR with Taq polymerase (Invitrogen, San
Diego) was performed with 1 cycle at 94 for 5 min; 30 cycles at
94 for 30 sec, at 55 for 30 sec, and at 72 for 2 min; and then at
72 for 10 min. The 700-bp PCR product was digested with StuI
and XhoI and the resulting 406-bp fragment was ligated to
pRS305-HSF1, which had been predigested with StuI and XhoI.
Yeast strains and cultures: Yeast strains used in this study are
listed in Table 2. To generate the wt-HSF or DCTA-HSF in-
tegrated strains, the integrating constructs pRS305-HSF1 or
pRS305-DCTAHSF1 was digested with ClaI and transformed
into a 74D-694 (½psi½RNQ1) strain whose chromosomal HSF1
was disrupted with a kanR but contained a pRS416-HSF1
plasmid for viability (Park et al. 2006). Transformants selected
on SC–ura–leu were streaked on SC–leu15-FOA to eliminate
the pRS416-HSF1 and the resulting strains were termed 74D-
694-I-wtHSF and 74D-694-I-DCTAHSF, respectively.
To create sse1D strains, the disruption construct of sse1D::
LEU2 (Shaner et al. 2004) was digested with SacII and PstI. The
resulting digestion mixture was transformed into various
isogenic strains with different prion backgrounds as shown
in Table 2. In all cases, SSE1 disruption was confirmed by
immunoblot analysis using a polyclonal Sse1 antibody, a kind
gift from J. Brodsky’s laboratory.
TABLE 1
Plasmids used in this study
Plasmid Promoter Marker Copy number Source
pCUP1-GFP CUP1 URA3 CEN, low Park et al. (2006)
pCUP1-NMGFP CUP1 URA3 CEN, low Park et al. (2006)
pRS313CUP1-GFP CUP1 HIS3 CEN, low Derkatch et al. (2001)
pRS313CUP1-NMGFP CUP1 HIS3 CEN, low Derkatch et al. (2001)
p426GPDSSE1 GPD URA3 2m high Morano lab
p423STI1 STI1 HIS3 2m high Song et al. (2005)
pGAL-NMGFP GAL HIS3 CEN, low Park et al. (2006)
p2UGHSP82 GPD URA3 2m, high Lindquist lab
pKAT6 GPD HIS3 2m, high Lindquist lab
sse1DTLEU2 LEU2 Replacement, single Morano lab
p414TEF SSE1 TEF TRP1 CEN, low Morano lab
p414TEF SSE1K69Q TEF TRP1 CEN, low Morano lab
p414TEF SSE1G233D TEF TRP1 CEN, low Morano lab
p414TEF SSE1PBD TEF TRP1 CEN, low Morano lab
pRS305-HSF1 HSF1 LEU2 Integrating, single This study
pRS305-DCTAHSF1 HSF1 LEU2 Integrating, single This study
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The weak ½PSI1 variant, ½PSI1W, was obtained from 74D-694
cells (½psi½RNQ1) after transient overexpression of SUP35
NMGFP as described (Park et al. 2006).
Yeast cultures and other genetic manipulations were per-
formed according to the established protocols (Sherman 1991).
[PSI+] induction and variant determination: ½PSI1 induc-
tion in cells containing pCUP1-NMGFP was performed as de-
scribed previously (Park et al. 2006). Briefly, cells were grown
in selective media at 30 overnight before diluted into fresh
media at a density of43 106 cell/ml. After an additional 1 hr
of growth at 30, CuSO4 was added to a final concentration of
34mm. At various induction times, cells were spotted with a five-
fold serial dilution onto SC-ade and YPD plates. ½PSI1 induction
in cells containing pGAL-NMGFP was carried out by growing
cells in selective media with 2% raffinose to mid-log phase
(A600 ¼ 0.5) before adding galactose to a final concentration
of 2% to induce Sup35NMGFP production. As time indicated,
cultures were spread onto SC–ade and YPD plates to obtain
individual colonies. In all cases, Ade1 colonies were considered
as ½PSI1 candidates but only GdnHCl-curable Ade1 isolates were
scored as ½PSI1. Subsequent ½PSI1 confirmation and variant
determination were carried out as described (Park et al. 2006).
For experiments described in Figure 2, isogenic strains of
74D-694-I-wtHSF and 74D-694-I-DCTAHSF (see Table 2 for strain
descriptions) were cotransformed with either pRS313CUP1-
NMGFP and p2UGHSP82 or pRS313CUP1-NMGFP and p426
GPDSSE1. To examine the overexpression effect of STI1, the
same cells were transformed with pCUP1-NMGFP and pRS423
STI1 (a kind gift from D. Masison). ½PSI1 de novo formation was
analyzed using cell patches as described (Derkatch et al.
2001). Briefly, individual transformants were patched onto
plates selective for the containing plasmids followed by replica
plating onto plates containing 70 mm CuSO4. After incubation
for20 hr at 30, the cell patches were replica plated onto SC–
ade to view potential ½PSI1 colonies. To quantify ½PSI1 de novo
formation (Figure 2, right), three individual transformants of
each transformation were grown in liquid media selective for
the indicated plasmids to early log phase followed by addition
of CuSO4 to a final concentration of 34 mm. After 4 hr of
induction, cells were counted and spotted onto SC–ade and
YPD plates with a fivefold serial dilution. Ade1 colonies that
were cured by GdnHCl were scored as ½PSI1. The ratio of ½PSI1
to the total number of viable cells (calculated from colonies on
the YPD plates) was used to determine the frequency of ½PSI1
de novo formation.
To determine the effect of sse1D on ½PSI1 de novo formation
(shown in Figure 3), an SSE1 disruption strain of 74D-694
(½psi½RNQ1) and the isogenic wild-type strain (½psi½RNQ1)
were transformed with pCUP1-NMGFP and the resulting trans-
formants were assayed for ½PSI1 de novo formation using CuSO4
as an inducer as described above. ½PSI1 determination and
calculation of ½PSI1 appearance percentage were also carried
out as described above. At least three transformants were used
for each experiment and results from three independent
transformations were summarized.
Sup35NMGFP fluorescence microscopic assay: 74D-694
cells (½psi½RNQ1) containing pRS313CUP1-NMGFP and
p426GPDSSE1 or p426GPD were grown in SC–his–ura to early
log phase. After a 4-hr induction upon addition of CuSO4 to
34 mm, the fluorescence patterns of Sup35NMGFP were ex-
amined under a fluorescence microscope as described pre-
viously (Park et al. 2006).
SDS–PAGE and immunoblot analyses: Yeast cells grown
overnight in either YPD (Sse1 immunoblot analysis) or selec-
tive media to mid-log phase (½PSI1 induction experiments)
were harvested by centrifugation at 3000 rpm for 3 min fol-
lowed by washing once with sterile water. The washed cells
were used for preparing total protein extracts by the ethanol
lysis method (Park et al. 2006). The resulting protein extracts
were analyzed by SDS–PAGE and immunoblot analysis as de-
scribed previously (Park et al. 2006). Antibodies used in this
study were kindly provided by S. Lindquist (Hsp104, Hsp90,
and Rnq1), E. Craig (Ssa, Ssb, and Sis1), J. Brodsky (Sse1), and
S. Liebman (Sup35).
Semidenaturing agarose gel electrophoresis: Crude pro-
tein extracts prepared from isogenic strains of 74D-694
TABLE 2
Strains of S. cerevisiae used in this study
Strain Genotype description Source
74D-694 [psi][RNQ1] MATa: ade1-14, trp1-289, his3D-200, ura3-52, leu2-3,
112, [psi][RNQ1]
Chernoff et al. (1995)
74D-694 [PSI1]S[RNQ1] MATa: ade1-14, trp1-289, his3D-200, ura3-52, leu2-3,
112, [PSI1]S[RNQ1]
Chernoff et al. (1995)
74D-694 [psi][rnq] MATa: ade1-14, trp1-289, his3D-200, ura3-52, leu2-3,
112, [psi][rnq]
Sondheimer and Lindquist (2000)
74D-694 [PSI1]W[RNQ1] MATa: ade1-14, trp1-289, his3D-200, ura3-52, leu2-3,
112, [PSI1]W[RNQ1]
This study
74D-694 [psi][RNQ1] sse1D MATa: ade1-14, trp1-289, his3D-200, ura3-52, leu2-3,
112, [psi][RNQ1], sse1TLEU2
This study
74D-694 [PSI1]S[RNQ1] sse1D MATa: ade1-14, trp1-289, his3D-200, ura3-52, leu2-3,
112, [PSI1]S[RNQ1], sse1TLEU2
This study
74D-694 [psi][rnq] sse1D MATa: ade1-14, trp1-289, his3D-200, ura3-52, leu2-3,
112, [psi][rnq], sse1TLEU2
This study
74D-694-I-wtHSF MATa: ade1-14, trp1-289, his3D-200, ura3-52, leu2-3,
112, [psi][RNQ1], hsf1TkanR, pRS305HSF1
integrated at the leu2 locus
This study
74D-694-I-DCTAHSF MATa: ade1-14, trp1-289, his3D-200, ura3-52, leu2-3,
112, [psi][RNQ1], hsf1TkanR, pRS305-DCTAHSF1
integrated at the leu2 locus
This study
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½PSI1S½RNQ1, ½PSI1W½RNQ1, and their corresponding sse1D
derivatives were subjected to SDS–PAGE analysis according to
Bagriantsev et al. (2006) with minor modifications. Briefly,
yeast cultures were grown in liquid YPD media to A600 of 1.5–
2.0 and harvested by centrifugation at 3000 rpm for 3 min.
After washing once with sterile water, the cell pellet was sus-
pended in the extraction buffer containing 50 mm Tris–HCl
(pH 7.5), 50 mm KCl, 10 mm MgCl2, 5% glycerol, 8 mg/ml
aprotinin, 8 mg/ml leupeptin, 10 mm phenylmethylsulfonyl
fluoride (PMSF), and protease inhibitor cocktail (Roche pro-
tease inhibitor complete mini, 1/2 tablet/10 ml). After homog-
enization for 4 3 1 min in a bead beater with 0.5-mm glass
beads, the crude lysates were centrifuged at 600 3 g for 1 min
at 4. The supernatant was incubated for 7 min in the sample
buffer containing 50 mm Tris–HCl (pH 6.8), 5% glycerol, 2%
SDS, and 0.05% bromophenol blue at room temperature be-
fore being loaded onto a 1.5% horizontal agarose gel as de-
scribed (Bagriantsev et al. 2006).
RESULTS
The role of Sse1 in [PSI+] de novo formation: Sse1 is
the ortholog of the mammalian Hsp110 and has been
identified as a potent Hsp70 nucleotide exchange factor
(Dragovic et al. 2006; Raviol et al. 2006; Shaner et al.
2006). BecauseDCTA-HSF dramatically influences the de
novo formation of ½PSI1 and Sse1 is a CTA-HSF target,
we decided to examine whether manipulating the ex-
pression levels of SSE1 would have any effects on ½PSI1
de novo formation. ½PSI1 can arise spontaneously from
½psi cells with a very low frequency (Tuite et al. 1981).
However, ½PSI1 formation can be greatly enhanced by
Sup35 overproduction in the presence of another prion,
½RNQ1 (Chernoff et al. 1993; Derkatch et al. 1997). To
examine if overexpression of SSE1 would affect ½PSI1 de
novo formation, we transformed 74D-694 (½psi½RNQ1)
cells with pGAL-NMGFP, a galactose-inducible plasmid
expressing a GFP fusion of the N-terminal and middle
regions of Sup35 (1–265 aa), and p426GPDSSE1, a strong
constitutive SSE1 expression plasmid. The resulting
transformants were analyzed for ½PSI1 de novo forma-
tion. Since the GAL promoter is tightly regulated, it was
possible to analyze how Sse1 overproduction could ki-
netically affect ½PSI1 de novo formation. As shown in
Figure 1A, Sse1 overproduction dramatically stimulated
½PSI1 formation throughout the time course of study.
After 72-hr induction with galactose, the average ½PSI1
formation in cells containing the SSE1 overexpression
plasmid p426GPDSSE1 was 8.7% whereas cells con-
taining the empty vector p426GPD had an average ½PSI1
formation rate of 0.06%, an 145-fold difference. The
stimulatory influence of Sse1 on ½PSI1 formation was
also evident when Sup35NMGFP was overproduced un-
der the regulation of a CUP1 promoter (pRS313CUP1-
NMGFP). Upon CuSO4 addition, the number of Ade1
colonies derived from cells containing pRS313CUP1-
NMGFP and p426GPDSSE1 was significantly greater than
that derived in cells containing pRS313CUP1-NMGFP
and p426GPD (Figure 1C, top). However, the stimula-
tory effect of Sse1 on ½PSI1 formation was less dramatic
when the CUP1 promoter was used. After a 4-hr induc-
tion, the difference in ½PSI1 formation in the presence
or absence of Sse1 overproduction was 10-fold. This
smaller difference is likely due to the fact that the CUP1
promoter is not tightly regulated (Tamai et al. 1994;
Hahn et al. 2004). We also examined the pattern of
Sup35NMGFP fluorescence in the presence of overpro-
duced Sse1. As shown in Figure 1B, the observed
Sup35NMGFP fluorescent foci in cells containing
p426GPDSSE1 (20%) is significantly more than that
of cells containing the empty vector p426GPD (0.2%).
We conclude that overproduction of Sse1 promotes
both Sup35NMGFP aggregation and ½PSI1 formation.
It has been shown that overproduction of Sse1 re-
duces cell growth (Liu et al. 1999; Shaner et al. 2004).
We also observed that the SSE1 overexpression construct
p426GPDSSE1 reduced transformation efficiency (data
not shown). To exclude the possibility that the stimu-
lating effect of Sse1 overproduction on ½PSI1 formation
is caused by chromosomal mutations in the SSE1-over-
expressing cells, we eliminated p426GPDSSE1 from cells
containing pRS313CUP1-NMGFP and exhibiting stimu-
latory effects on ½PSI1 formation. As shown in Figure 1C
(bottom), the elimination of p426GPDSSE1 resulted in
loss of the stimulatory effect on ½PSI1 de novo formation.
Thus, the observed ½PSI1 promoting effect was not due
to a chromosomal mutation(s). Rather, overproduction
of Sse1 is the primary responsible factor.
To further investigate whether this ½PSI1-promoting
effect was caused indirectly by modulating other cellular
factors in response to Sse1 overproduction, we exam-
ined the expression levels of several molecular chaper-
ones known to influence ½PSI1: Hsp104, Ssa1/2, Ssb1/
2, and Sis1. Since Sse1 has been identified as an Hsp90
co-chaperone (Liu and Thiele 1999), we also examined
the expression levels of Hsp90 and its co-chaperone
Sti1. As shown in Figure 1D, all examined molecular
chaperones displayed similar expression levels in cells
with or without overproduction of Sse1, except Hsp104,
which increased about twofold in cells overproducing
Sse1.
Next, we examined if other CTA-HSF targets—Hsp90,
Sti1, Cpr6, and Ydj1—would have effects similar to Sse1
on ½PSI1 de novo formation. Interestingly, as shown in
Figure 2, striking differences were observed for differ-
ent CTA-HSF targets. In contrast to Sse1, overexpression
of HSP82 severely inhibited ½PSI1 formation (Figure 2).
Similar results were also obtained when HSC82 was
overexpressed (data not shown). As shown in Figure 2,
overproduction of Sti1 also strongly inhibits ½PSI1
formation. However, elevated expression levels of Cpr6
and Ydj1 had no significant effects on ½PSI1 de novo
formation (data not shown). The same experiments
were also conducted for DCTA-HSF cells. As shown in
Figure 2, in all cases, DCTA-HSF cells gave rise to
significantly more Ade1 colonies than wt-HSF cells did,
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confirming our previous report that DCTA-HSF stimu-
lates ½PSI1 de novo formation (Park et al. 2006). However,
the inhibitory effects upon Hsp90 and Sti1 overproduc-
tion and the stimulatory effect upon Sse1 overproduction
were also evident in DCTA-HSF cells (Figure 2). Since
overproduction of each individual CTA-HSF target re-
sulted in similar effects in both wt-HSF and DCTA-HSF
cells, it is unlikely that the observed effects by Hsp90,
Sti1, or Sse1 overproduction were caused by the dele-
tion of the CTA of HSF. Our results thus demonstrate
that different components of the Hsp90 complex play
distinct roles in ½PSI1 de novo formation.
The effects of SSE1 disruption on [PSI+] formation
and variant determination: To further analyze the role
of Sse1 in ½PSI1 regulation, we next examined the effect
of SSE1 disruption on ½PSI1 de novo formation. A chro-
mosomal SSE1 disruption strain (sse1D) was created in
74D-694 (½psi½RNQ1). After transformation with
pCUP1-NMGFP, isogenic sse1D and wild-type cells were
assayed for ½PSI1 induction. If Sse1 is a ½PSI1-promoting
factor, SSE1 disruption would be expected to abolish or
reduce ½PSI1 formation. As shown in Figure 3A, the
number of ½PSI1 colonies was indeed greatly reduced in
sse1D cells when compared to that of wild-type cells. To
examine if sse1D also affects ½PSI1 variant determina-
tion, Ade1 colonies formed in sse1D and isogenic wild-
type cells were randomly picked and streaked onto YPD
plates to view their colony appearances. Interestingly, all
Ade1 cells formed in sse1D cells had the appearance of
very weak ½PSI1 variants, which were unstable and ap-
peared undifferentiated (Figure 3B). This appearance
is similar to that of an unstable, undifferentiated ½PSI1
variant (½PSI1U) formed in DCTA-HSF cells (Park et al.
2006). A careful, side-by-side comparison of ½PSI1U cells
formed in DCTA-HSF and sse1D cells under identical
induction conditions, however, revealed distinct colony
morphologies. As shown in Figure 3C, the DCTA½PSI1U
colonies are more distinctly sectored but the sse1D½PSI1U
colonies do not have clear sectoring boundaries. Multiple
independent ½PSI1 induction experiments were con-
ducted and no uniformly colored white or pink colonies
were observed in sse1D cells. Despite repeated efforts, we
were not able to transfer ½PSI1U formed in sse1D cells
to wild-type ½psi cells through mating/sporulation.
sse1D½PSI1U is easily lost during the mating process to
yield ½psi diploids. Thus, ½PSI1U formed in sse1D cells is
Figure 1.—TheinfluenceofSse1over-
production on ½PSI1 de novo formation.
(A) Overproduction of Sse1 dramatically
increases ½PSI1 de novo formation. Yeast
cells (74D-694 ½psi½RNQ1) containing
pGAL-NMGFP and p426GPDSSE1 (SSE1)
or pGAL-NMGFP and p426GPD (vector)
were assayed for ½PSI1 de novo formation
as described inmaterials andmethods.
(Top) A representative spotting assay of
½PSI1 de novo formation. Pictures were
taken after 7 days of growth at 30 for SC–
ade and after 3 days for YPD. (Bottom)
Kinetic analysis of ½PSI1 de novo forma-
tion in the presence or absence of Sse1
overproduction as described in materi-
als and methods. Data shown are aver-
ages of five independent experiments.
(B) Overproduction of Sse1 promotes
Sup35NMGFPaggregation.Cellscontain-
ing pRS313CUP1-NMGFP, p426GPDSSE1
(SSE1[, NMGFP[) or pRS313CUP1-
NMGFP, p426GPD (vector, NMGFP[) were
assayed for Sup35NMGFP aggregation
using a fluorescence microscope as de-
scribed in materials and methods.
(Top) Representative images of cells ex-
pressing Sup35NMGFP in the presence
(SSE1) or absence (vector) of Sse1 over-
production. (Bottom) The average percen-
tage of cells containing Sup35NMGFP
aggregates from five independent experi-
ments. For each experiment,.2000 cells
with or without SSE1 overexpression were
examined. (C) ½PSI1-promoting effect in cells overproducing Sse1 was not caused by chromosomal mutations. The same cells used in
B were also assayed for ½PSI1 de novo formation (top). After eliminating theURA3 plasmids (p426GPDSSE1 and p426GPD) after grow-
ing in 5-FOA, cells were reassayed for ½PSI1 de novo formation (bottom). (D) Immunoblot analysis of selected molecular chaperones.
Cellsdescribed inBwere harvestedaftera4-hr induction.Proteinextracts werepreparedusinganethanol lysismethodandexamined
by SDS–PAGE and immunoblot analysis as described previously (Park et al. 2006).
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extremely unstable and poorly transmitted. In compari-
son, DCTA½PSI1U can be easily transmitted to wild-type
cells as ½PSI1W (Park et al. 2006).
We also examined the steady-state levels of several
molecular chaperones in sse1D cells. As shown in Figure
3D, there were no significant changes in expression of
the examined molecular chaperones, including Ssa1/2,
Ssb, Hsp104, Sis1, Sti1, and Hsp90. Our data suggest
that the lack of Sse1 is responsible for the observed
reduction in ½PSI1 formation and deficiency in variant
determination.
Mutational analysis of SSE1 on [PSI+] variant deter-
mination: As a nucleotide exchange factor, Sse1 stim-
ulates ADP release from ADP-bound Hsp70 to allow it to
rebind to ATP and thus promotes the Hsp70 cycle. This
ADP/ATP exchange is essential for refolding thermally
denatured luciferase (Dragovic et al. 2006; Raviol et al.
2006). The nucleotide exchange function of Sse1 requires
the ATP-binding domain and the substrate-binding do-
main (Dragovic et al. 2006; Raviol et al. 2006; Shaner
et al. 2006). Mutations predicted to abolish ATP hydro-
lysis in Sse1 do not affect its function in vivo or in vitro,
while those that block nucleotide binding also prevent
the binding to Hsp70 (Dragovic et al. 2006; Raviol
et al. 2006; Shaner et al. 2006). For example, Sse1-K69Q,
a mutation that inhibits ATP hydrolysis in other Hsp70s,
retains Hsp70-binding capability; Sse1-G233D, however,
cannot bind to ATP or Hsp70 and Sse1-PBD, which
contains only the carboxyl terminal peptide (substrate)-
binding domain, is likewise inactive in vivo (Shaner et al.
2004; Shaner et al. 2006). To test if the observed Sse1
effects on ½PSI1 variant determination are due to the
chaperone’s function as an Hsp70 NEF, we analyzed
½PSI1 variants formed in the cells whose endogenous
SSE1 was disrupted but which contain a CEN plasmid
expressing one of the three described sse1 mutants.
Ade1 colonies formed in these mutant cells were ran-
domly picked and streaked onto YPD to view their colony
appearances. As shown in Figure 3E, cells expressing
wild-type SSE1 and SSE1-K69Q gave rise to ½PSI1 variants
from very weak to very strong. Cells expressing SSE1-
G233D or SSE1-PBD gave rise only to ½PSI1U, an unstable
½PSI1 variant with the same colony appearance as that of
½PSI1U formed de novo in sse1D cells. To exclude the
possibility that the differences that we observed among
the different sse1 mutants were due to differences in
their expression levels or stabilities, the steady-state lev-
els of individual Sse1 mutant proteins were estimated by
immunoblot analysis using a polyclonal antibody rec-
ognizing Sse1. As shown in Figure 3F, there was no
reactive Sse1 band in protein extracts prepared from the
sse1D cells transformed with an empty vector (lane 2),
confirming that the chromosomal SSE1 was disrupted.
However, immunoblot of protein extracts prepared from
sse1D cells containing p414TEFSSE1, p414TEFSSE1K69Q,
or p414TEFSSE1G233D indicated that all SSE1 alleles
were expressed at similar levels. Since ectopic expression
of these SSE1 alleles in wild-type cells gave rise to ½PSI1
variants with a full spectrum from very weak to very
strong, the effects of these sse1 mutant alleles on ½PSI1
variant establishment are not dominant (data not
shown). Taken together, our data suggest that the bind-
ing of Sse1 to Hsp70, with concomitant NEF activity, is
essential for establishing a full spectrum of distinct ½PSI1
variants.
The influence of Sse1 on [PSI+] propagation: We also
investigated the role of Sse1 in ½PSI1 propagation. In
agreement with a recent report (Kryndushkin and
Wickner 2007), we observed that overproduction of
Sse1 has no effect on preexisting ½PSI1, either ½PSI1S or
Figure 2.—Overproduction of Hsp90
and Sti1 severely inhibits ½PSI1 de novo
formation. Cells of isogenic 74D-694-I-
wtHSF and 74D-694-I-DCTAHSF (see Ta-
ble 2 for the descriptions of the strains)
containing pRS313CUP1-NMGFP and
p2UGHSP82 (HSP82), pRS313CUP1-
NMGFP p426GPDSSE1 (SSE1), or pCUP1-
NMGFP and pRS423STI1 were assayed
for ½PSI1 de novo formation as described
inmaterials andmethods. (Left) Rep-
resentative cell patches showing de novo
formation of putative ½PSI1 colonies;
(Right) Quantified data of ½PSI1 de novo
formation using a spotting assay as de-
scribed in materials and methods.
Data shown are from three independent
experiments.
1588 Q. Fan et al.
½PSI1W (data not shown). Disruption of SSE1, however,
dramatically influences ½PSI1 propagation. Figure 4A
(left) shows representative streaks of isogenic 74D-694
cells of ½PSI1S, ½PSI1W, and their corresponding SSE1
disruption derivatives. SSE1 disruption was confirmed
by immunoblot analysis (Figure 4A, right). The sse1D
derivatives of ½PSI1S had a redder colony appearance
than that of the ½PSI1S control (Figure 4A, left), sug-
gesting that either a new ½PSI1 variant was reestablished
upon sse1D or the ½PSI1W-like phenotype was a different
readout of ½PSI1S in sse1D genetic background. Upon
SSE1 disruption, ½PSI1W appeared as red as ½psi cells
(Figure 4A, left). This indicates that either sse1D cured
½PSI1W or the ½PSI1W phenotype was masked in the sse1D
background. For further clarification, we crossed the
sse1D derivatives of both ½PSI1S and ½PSI1W with isogenic
½psi cells containing the wild-type SSE1 gene. As shown
in Figure 4B, the diploids derived from sse1D½PSI1S 3
½psi had the ½PSI1S colony appearance, indicating that
disruption of SSE1 in ½PSI1S did not change ½PSI1S into a
weaker variant. The pink appearance is thus a modified
readout of ½PSI1S in sse1D background. This conclusion
was further supported by results from sporulation of the
sse1D/SSE1 diploids of ½PSI1S, which gave rise to four
spores with a ratio of 2:2 of ½PSI1S to ½PSI1W-like spores
(Figure 4B). The ½PSI1W-like spores were verified to be
sse1D cells as the colonies were smaller and they were
able to grow on SC–leu media (SSE1 was disrupted by a
Figure 3.—The effects of sse1 disrup-
tion on ½PSI1 formation, variant determi-
nation, and steady levels of selective
molecular chaperones. (A) SSE1 disrup-
tion severely inhibits ½PSI1 formation.
Isogenic cells of 74D-694 (½psi½RNQ1)
with (sse1D) or without sse1 disruption
(wild type) containing pCUP1SUP35NM
GFP were assayed for ½PSI1 de novo for-
mation assay as described in materials
and methods. The averages of three in-
dependent experiments are shown. (B)
sse1D cells give rise only to an unstable
and undifferentiated ½PSI1 variant,
½PSI1U. As shown are representative cell
streaks and enlarged colonies from sse1D
cells. (C) ½PSI1U formed in sse1D and
DCTA-HSFcells is morphologically differ-
ent. Enlarged images of ½PSI1U colonies
derived from sse1D and DCTA-HSF cells
under identical experimental conditions
are shown. (D) SSE1 disruption has no
significant effects on the expressions of
a selective group of molecular chaper-
ones. Protein extracts were prepared
from isogenic wild-type and sse1Dcells us-
ing the ethanol lysis method and were ex-
amined by SDS–PAGE/immunoblot
analysis as described in materials and
methods. Rnq1 was used as the loading
control. wt, wild type. (E) Physical associ-
ation of Hsp70 to Sse1 is important for
½PSI1 variant determination. 74D-694
sse1D cells (½psi½RNQ1, sse1TLEU2)
containing pCUP1-NMGFP and one of
the following plasmids: p414TEF (sse1D),
p414TEF-SSE1 (SSE1), p414TEF-SSE
1K69Q (K69Q), p414TEF-SSE1G233D
(G233D), and p414TEF-SSE1PBD (PBD)
were assayed for ½PSI1 de novo formation
as described in A. Newly formed ½PSI1
colonies were randomly picked and
streaked onto YPDplates toviewtheircol-
ors. Plus (1) and minus () represent
½PSI1 and ½psi controls, respectively.
(F) Immunoblot analysis of Sse1. Prior
to the ½PSI1 induction assay, protein extracts were prepared from cultures indicated and analyzed by SDS–PAGE and immunoblot
analysis using an anti-Sse1 as described in materials and methods. Lane 1, 74D-694 wild-type cells (control); lanes 2–6, sse1D cells
containing p414TEF (vector), p414TEF-SSE1 (SSE1), p414TEF-SSE1K69Q (K69Q), p414TEF-SSE1G233D (G233D), and p414TEF-
SSE1PBD (PBD), respectively.
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LEU2 marker). In this regard, it has been reported that
sse1 null mutants grow more slowly than isogenic wild-
type cells (Liu et al. 1999). In contrast to masking the
½PSI1S phenotype, results from similar crosses of ½PSI1W
to ½psi indicate that sse1D had caused ½PSI1W loss. As
shown in Figure 4B, diploids derived from sse1D½PSI1W
and ½psi had the ½psi colony appearance. Upon spor-
ulation, they gave rise to four spores that were all ½psi,
indicating that ½PSI1 was eliminated in the sse1D cells.
Subsequent analysis confirmed that none of the spores
were able to grow in SC–ade media (data not shown).
Analyzing the effect of sse1D on the polymer sizes of
Sup35: Semidenaturing agarose gel electrophoresis
(SDAGE) is a useful technique that can be applied to
analyze any SDS-stable amyloid protein aggregate, such
as the prion polymers of Sup35 and Rnq1 in ½PSI1 and
½RNQ1 cells (Kryndushkin et al. 2003; Bagriantsev
and Liebman 2004; Salnikova et al. 2005). To examine
if the disruption of SSE1 would result in changes in
Sup35 polymer sizes, we carried out the SDAGE exper-
iment followed by immunoblot analysis using Sup35
antibody as described (Bagriantsev et al. 2006). As
shown in Figure 5, disruption of SSE1 in ½PSI1S cells
resulted in formation of larger-sized Sup35 polymers,
which are similar to that of the ½PSI1W variant. However,
disruption of SSE1 in ½PSI1W cells resulted in a complete
loss of Sup35 polymers, confirming that ½PSI1W was
indeed eliminated upon SSE1 disruption. The de novo-
formed sse1D½PSI1U cells have the average size of Sup35
polymers similar to that of ½PSI1W cells but with a much
lower yield. This is likely due to the fact that some ½PSI1
elements were lost during the culturing process as a
result of ½PSI1U instability or of the lower amount of
Sup35 polymers contained in the sse1D½PSI1U cells.
DISCUSSION
The yeast Sse1 protein is a member of the Hsp70
family and the ortholog of the mammalian Hsp110. It
shares high sequence homology with another yeast
Hsp110 protein, Sse2 (Mukai et al. 1993). Both purified
Sse1 and the mammalian Hsp110 can act as ‘‘holdases’’
that bind to unfolded proteins and maintain them
in folding-competent conformations (Oh et al. 1997;
Brodsky et al. 1999). The function of Sse2 is less under-
stood and its role in ½PSI1 biology has not been inves-
tigated. Recently, Sse1 was identified as a nucleotide
exchange factor for cytosolic Hsp70 members, includ-
ing Ssa1 and Ssb1 (Dragovic et al. 2006; Raviol et al.
2006; Shaner et al. 2006). In S. cerevisiae, there are four
isoforms of Ssa proteins, Ssa1–4, and two isoforms of Ssb
proteins, Ssb1/2, which are collectively termed Ssa and
Ssb, respectively. Interestingly, Ssa and Ssb exhibit com-
pletely opposite effects with respect to the de novo for-
mation and propagation of the yeast prion ½PSI1. Ssa
promotes whereas Ssb antagonizes ½PSI1. For example,
overproduction of Ssa prohibits whereas overproduction
of Ssb promotes ½PSI1 curing by Hsp104 overproduc-
tion (Chernoff et al. 1999). Moreover, overproduction
of Ssa but not Ssb enhances ½PSI1 de novo formation
(Allen et al. 2005). Although Sse1 is a nucleotide
exchange factor for both Ssa and Ssb proteins, we
speculate that Sse1 affects ½PSI1 mainly through Ssa
function. Like Ssa, Sse1 behaves as a ½PSI1-promoting
Figure 4.—The effects of SSE1 dis-
ruption (sse1D) on ½PSI1 propagation.
(A) The disruption of SSE1 weakens
½PSI1S and cures ½PSI1W. (Left) Repre-
sentative streaks of isogenic ½PSI1 var-
iants and their corresponding sse1D
derivatives. (Right) Immunoblot analy-
sis to confirm that SSE1 was disrupted
in the indicated sse1D derivatives shown
at the left. (B) Mating/sporulation anal-
ysis to confirm the effects of sse1D on
½PSI1 propagation. ½PSI1S and ½PSI1W
cells with or without SSE1 disruption
were crossed with the a cells of 74D-694
(½psi½rnq) and the resulting diploids
and spores are shown.
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factor (Allen et al. 2005; Figure 1A). However, the
promoting effect of Sse1 on ½PSI1 is much more pro-
found than that of Ssa proteins. Under identical condi-
tions, we found that the amount of ½PSI1 formed under
Sse1 overproduction conditions was significantly more
than that formed under Ssa1 overproduction condi-
tions (data not shown). It is possible that the excess Sse1
can more efficiently stimulate the function of Ssa than
Ssb. In support of this notion, Sse1 preferentially asso-
ciates with Ssa in vivo (Shaner et al. 2005). The ratio of
Sse1 in association with Ssa or with Ssb is balanced by at
least two factors: relative abundance and their binding
affinity to Sse1. When Sse1 is overproduced, Sse/Ssa
heterodimers are likely to accumulate, promoting the
ADP/ATP exchange of Ssa, and thus exhibit an effect
similar to that of Ssa overproduction. The fact that over-
production of either Ssa1 (Schwimmer and Masison
2002) or Sse1 (this study) has no effect on preexist-
ing ½PSI1 but either treatment is able to cure ½URE3
(Schwimmer and Masison 2002; Kryndushkin and
Wickner 2007) further suggests that the effect of Sse1
overproduction on ½PSI1 is through Ssa1.
A fascinating phenomenon of prion biology is the
existence of ‘‘strains’’ or variants. There are multiple
PrPSc forms described, which are associated with distinct
prion diseases varying in symptoms, incubation times,
and brain pathologies (Prusiner 1998). All identified
yeast prions are able to exist in multiple variants
(Derkatch et al. 1996; Sondheimer and Lindquist
2000; Schlumpberger et al. 2001). Despite decades of
effort, it remains unclear how a prion polypeptide
adopts multiple heritable conformations. Identification
of cellular factors responsible for establishing multiple
prion conformations will likely shed light on the under-
lying mechanism required for prion variant determina-
tion. Although sse1D cells are capable of propagating
the strong variant of ½PSI1 (Figure 4A), we have not
been able to obtain uniformly colored pink or white
colonies from sse1D cells upon Sup35 overproduction.
Only ½PSI1U was permitted to form de novo in sse1D cells.
Thus Sse1 is an important ½PSI1 variant determinant.
Our finding that the physical association of Hsp70 with
Sse1 is required for establishing a full spectrum of ½PSI1
variants suggests that the concerted action of Sse1–Ssa
and/or Sse1–Ssb might be a key to ½PSI1 variant deter-
mination. In this regard, it has been shown that over-
produced Sup35-HA is physically associated with Ssa
and Ssb both in vivo and in vitro (Allen et al. 2005).
We have previously shown that DCTA-HSF cells pref-
erentially give rise to a weak ½PSI1 variant that is un-
stable, DCTA½PSI1U (Park et al. 2006). Although Sse1 is a
CTA-HSF target (Liu and Thiele 1999) and is impor-
tant for ½PSI1 variant establishment (Figure 3), the ef-
fect of DCTA-HSF on ½PSI1 variant formation is unlikely
for several reasons due to the lack of Sse1. First, the
½PSI1U cells formed in sse1D cells have a unique colony
appearance that is distinct from that of ½PSI1U formed in
DCTA-HSF cells. As shown in Figure 3C, although both
DCTA½PSI1U and sse1D½PSI1U have a colony appearance
similar to very weak ½PSI1 variants, their detailed colony
morphologies are different. Second, sse1D½PSI1U is much
less stable than DCTA½PSI1U. Third, ecotopic expression
of SSE1 driven by promoters of variable strength cannot
change the preference of ½PSI1U formation in DCTA-
HSF cells (data not shown). Thus, the preference of
½PSI1U formation in DCTA-HSF cells is likely caused by
an unknown factor(s) other than Sse1. It is also possible
that the imbalance of molecular chaperones in the
DCTA-HSF cells is the responsible factor.
We have shown that overproduction of Sti1 and either
isoform of Hsp90 severely inhibited ½PSI1 de novo for-
mation whereas overproduction of Sse1 dramatically
stimulated it (Figure 2). Overproduction of Cpr6 or
Ydj1, however, exhibited no significant effects. Our find-
ing demonstrates that different Hsp90 co-chaperones
have distinct effects on ½PSI1 de novo formation and
variant determination. This finding is intriguing as the
Hsp90 complex is responsible for the maturation of a
large number of client proteins and is an important
Figure 5.—Analyzing Sup35 polymer sizes using SDAGE.
Crude protein extracts prepared from isogenic strains of
74D-694 (½PSI1S½RNQ1), (½PSI1W½RNQ1), and their corre-
sponding sse1Dderivativeswere subjected toSDAGEanalysis ac-
cording to Bagriantsev et al. (2006) with minor modifications
(see materials and methods). Lanes 1 and 2, ½PSI1S½RNQ1
and its sse1D derivative; lanes 3 and 4, ½PSI1W½RNQ1 and its
sse1D derivative; lanes 5 and 6, two ½PSI1U isolates derived from
sse1Dcells (½psi½RNQ1); andlane7, isogenicnonprioncontrol
cells (½psi½rnq). The arrow indicates the position to which the
Sup35 monomer has migrated.
Sse1 and Yeast Prion ½PSI1 Formation 1591
target for anticancer therapy. The effects of individual
components of the Hsp90 complex on ½PSI1 de novo
formation may be due to their dynamic association with
the Hsp90 complex. It is also possible that the Hsp90 co-
chaperones exercise distinct functions when they are or
are not in association with Hsp90. In this regard, it has
been shown that Sti1 and Cpr7 can also form stable
complexes with Hsp104 both in vivo and in vitro (Abbas-
Terkiet al. 2001). How such dynamic associations of Sti1
and Cpr7 with Hsp90 and Hsp104 affect ½PSI1 forma-
tion and propagation, however, has not been investigated.
Modulating the levels of one Hsp90 co-chaperone
might also affect the overall structure and integrity of
the Hsp90 complex and thus affect their associated
cofactors and client proteins. For example, overproduc-
tion of Hsp90 might cause more Sse1–Ssa1 complex to
be associated with Hsp90, thus reducing the Sup35
associated Sse1–Ssa1 complex. As a consequence, ½PSI1
de novo formation is reduced. However, increasing the
expression levels of Sse1 would promote the nucleotide
exchange of ADP to ATP of Ssa and thus enhance ½PSI1
formation. Although it is less likely, our results cannot
rule out the possibility that the Hsp90 complex directly
associates with Sup35 to affect ½PSI1 de novo formation.
A recent study by Kryndushkin and Wickner (2007)
showed that overproduction of Sse1 can efficiently cure
½URE3. However, results from both Kryndushkin and
Wickner (2007) and our independent study (data not
shown) indicate that overproduction of Sse1 has no
detectable effect on preexisting ½PSI1, including both
½PSI1S and ½PSI1W variants. The effect of sse1D on ½PSI1
is more complicated. Disruption of SSE1 weakens ½PSI1S
and completely eliminates ½PSI1W (Kryndushkin and
Wickner 2007; Figure 4). How altered SSE1 expression
levels affect ½RNQ1 has not been systematically investi-
gated. However, neither overexpression nor disruption
of SSE1 has detectable effects on the particular ½RNQ1
variant in the 74D-694 strains used in this study (data not
shown). Taken together, the Hsp110 chaperone Sse1 is
not only a prion-specific but also a variant-specific factor
that plays important and distinct roles in maintaining
various prion elements in yeast.
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